Skip to content

David Castle

28 papers in the library · 794 citations · publishing 0-2026

Papers

Sort Most recent Most cited

A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease.

Inflammatory bowel diseases March 2016 Kate Neilson, Maria Ftanou, Kaveh Monshat et al.

This study aimed to evaluate the feasibility, acceptability, and effectiveness of a mindfulness-based intervention for patients with inflammatory bowel disease (MI-IBD). Treatment-as-usual control versus mindfulness-based stress reduction intervention. Sixty patients participated in either the MI-IBD (n = 33) or treatment-as-usual group (n = 27) conditions. The MI-IBD consisted of an 8-week...

Cannabis, mind, and mirth.

European Psychiatry 1996 F Ames, David Castle

In the context of the discovery of the cerebral ligand for the cannabis receptor, and the elucidation of its genetic sequence, we discuss the psychomimetic properties of Cannabis sativa, and explore the relationship between cannabis intoxication and mood. We suggest that renewed study of acute cannabis encephalopathy would be rewarding not only in deepening our understanding of consciousness in...

A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.

Journal of Clinical Psychopharmacology Nicole Ledwos, Joshua D. Rosenblat, Daniel M. Blumberger et al. 16 citations

There has been resurgence of interest in the therapeutic use of serotonergic ("classic") psychedelics in major depressive disorder (MDD) and end-of-life distress. This commentary offers a critical appraisal of current evidence for antidepressant effects of classic psychedelics from contemporary clinical trials and highlights pitfalls that should be addressed before clinical translation. A...

DOI: 10.1097/jcp.0000000000001608 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Clinical research Depression treatment +1